Research coauthored by RTI Health Solutions experts will be presented at the 2022 San Antonio Breast Cancer Symposium.
Real-world treatment patterns and clinical outcomes in patients treated with Eribulin after prior PI3K inhibitor therapy for metastatic breast cancer. Goyal RK, Zhang J, Davis KL, Kaufman PA.
Poster P1-03-03
Treatment - Advanced Disease Treatment: Advanced Chemotherapy
Poster Session 1 – Tuesday, December 6, 2022: 5:00 pm CT
